J L Masferrer

Summary

Affiliation: Monsanto Company
Country: USA

Publications

  1. ncbi request reprint Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
    J L Masferrer
    GD Searle Monsanto Company, St Louis, Missouri 63167, USA
    Cancer Res 60:1306-11. 2000
  2. ncbi request reprint COX-2 inhibitors. A new class of antiangiogenic agents
    J L Masferrer
    Discovery Pharmacology and Analytical Sciences Center, G D Searle Monsanto Company, St Louis, Missouri 63167, USA
    Ann N Y Acad Sci 889:84-6. 1999
  3. ncbi request reprint Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers
    A T Koki
    Pharmacia Corporation, 700 Chesterfield Pkway N, BB3K, St Louis, MO 63198, USA
    Prostaglandins Leukot Essent Fatty Acids 66:13-8. 2002
  4. pmc Regulation of prostaglandin production by nitric oxide; an in vivo analysis
    D Salvemini
    G D Searle, Department of Molecular Pharmacology, St Louis, MO 63167, USA
    Br J Pharmacol 114:1171-8. 1995

Detail Information

Publications4

  1. ncbi request reprint Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
    J L Masferrer
    GD Searle Monsanto Company, St Louis, Missouri 63167, USA
    Cancer Res 60:1306-11. 2000
    ..The ability of celecoxib to block angiogenesis and suppress tumor growth suggests a novel application of this anti-inflammatory drug in the treatment of human cancer...
  2. ncbi request reprint COX-2 inhibitors. A new class of antiangiogenic agents
    J L Masferrer
    Discovery Pharmacology and Analytical Sciences Center, G D Searle Monsanto Company, St Louis, Missouri 63167, USA
    Ann N Y Acad Sci 889:84-6. 1999
    ..This novel antiangiogenic activity of COX-2 inhibitors indicates their potential therapeutic utility in several types of cancer...
  3. ncbi request reprint Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers
    A T Koki
    Pharmacia Corporation, 700 Chesterfield Pkway N, BB3K, St Louis, MO 63198, USA
    Prostaglandins Leukot Essent Fatty Acids 66:13-8. 2002
    ..These data collectively imply COX-2 may play an important role during premalignant hyperproliferation, as well as the later stages of invasive carcinoma and metastasis in various human epithelial cancers...
  4. pmc Regulation of prostaglandin production by nitric oxide; an in vivo analysis
    D Salvemini
    G D Searle, Department of Molecular Pharmacology, St Louis, MO 63167, USA
    Br J Pharmacol 114:1171-8. 1995
    ....